Plus: Amphista names Paul Medeiro CBO, and updates from Apellis, Forbion, Eqt, Egle, Spero, Molecular Templates and more

In first human RNA-editing data, Wave reports positive results from WVE-006 in alpha-1 antitrypsin deficiency

Conference showcases six emerging ADC payload types, and trends in antigen pairs for bispecific ADCs

San Diego company aims to be first to use functional AAT as a surrogate endpoint for AATD

Clinical programs include proteins, RNAi and small molecules, with gene editing getting in the game too

BioCentury’s roundup of preclinical news